share_log

5 Penny Stocks Insiders Are Buying

5 Penny Stocks Insiders Are Buying

内部人士正在买入5只细价股
Benzinga Real-time News ·  2022/01/18 06:50

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

当内部人士买卖股票时,这表明了他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易员可以在他们的整体投资或交易决策中考虑这一因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是最近几笔值得注意的细价股内幕交易。欲了解更多信息,请查看Benzinga的内幕交易平台。

Liberty Star Uranium & Metals

自由之星铀金属公司

  • The Trade: Liberty Star Uranium & Metals Corp. (OTC:LBSR) President and CEO Brett Gross acquired a total of 1395379 shares at an average price of $0.27. To acquire these shares, it cost $375,356.95.
  • What's Happening: The company's shares jumped around 54% over the past month.
  • What Liberty Star Uranium & Metals Does: Liberty Star Uranium & Metals Corp is an Arizona-based mineral exploration company. It is engaged in the acquisition, exploration, and development of mineral properties in Arizona and the southwest USA.
  • 行业: 自由之星铀金属公司(场外交易代码:LBSR)总裁和首席执行官布雷特·格罗斯以0.27美元的平均价格收购了总计1395379股。收购这些股份的成本为375,356.95美元。
  • 正在发生的事情:该公司的股价在过去一个月里上涨了约54%。
  • Liberty Star铀矿和金属公司的业务:Liberty Star铀矿公司是一家总部位于亚利桑那州的矿产勘探公司。该公司在亚利桑那州和美国西南部从事矿产资产的收购、勘探和开发。

Creatd

创建

  • The Trade: Creatd, Inc. (NASDAQ:CRTD) Co-Chief Executive Officer Jeremy Frommer acquired a total of 3251 shares at an average price of $2.00. The insider spent $6,509.56 to buy those shares.
  • What's Happening: The company's stock dropped around 43% over the previous six months.
  • What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Vocal Ventures, Creatd Partners, and Recreatd. Its flagship technology platform is Vocal, which provides creators of all shapes and sizes, from bloggers to podcasters, and more with best-in-class storytelling tools, safe and curated communities, and the opportunity to monetize their content.
  • 《贸易》Creatd公司纳斯达克(Sequoia Capital:CRTD)联席首席执行官杰里米·弗罗默以2美元的平均价格收购了总计3,251股。这位内部人士花了6509.56美元购买了这些股票。
  • 发生了什么事?:该公司的股票在过去六个月里下跌了约43%。
  • Creatd做了什么:Creatd Inc.通过技术和合作伙伴关系赋予创作者、品牌和企业家权力。该公司有三个平台,即Voice Ventures、Creatd Partners和Recreatd。它的旗舰技术平台是Voice,为从博客作者到播客的各种形状和规模的创作者,以及更多的人提供一流的讲故事工具、安全和精心策划的社区,以及将其内容货币化的机会。

Akerna

阿克尔纳

  • The Trade: Akerna Corp. (NASDAQ:KERN) Chief Operating Officer Cecil Ray Thompson Jr acquired a total of 6120 shares at an average price of $2.23. To acquire these shares, it cost $2,499.70. The insider also sold a total of 1230 shares.
  • What's Happening: The company's shares declined around 14% since the start of the year.
  • What Akerna Does: Akerna Corp is a United States-based company. The firm is the first compliance technology company in the cannabis space.
  • 《贸易》阿科尔纳公司纳斯达克(Sequoia Capital:KERN)首席运营官小塞西尔·雷·汤普森以2.23美元的平均价格收购了总计6,120股票。收购这些股份的成本为2,499.70美元。该内幕人士还出售了总计1,230股股票。
  • 发生了什么事?自今年年初以来,该公司的股价下跌了约14%。
  • 阿克尔纳做了什么:Akerna Corp是一家总部位于美国的公司。该公司是大麻领域第一家合规技术公司。

Avalo Therapeutics

阿瓦洛治疗公司

  • The Trade: Avalo Therapeutics, Inc. (NASDAQ:AVTX) Director Steven Boyd acquired a total of 455000 shares at an average price of $1.00. The insider spent $452,767.93 to buy those shares.
  • What's Happening: Avalo Therapeutics recently reported Phase 1b results for AVTX-002 in moderate to severe Crohn's disease patients and presented additional program updates at the 2022 investor event.
  • What Avalo Therapeutics Does: Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
  • 《贸易》Avalo治疗公司(纳斯达克股票代码:AVTX)董事史蒂文·博伊德以1美元的平均价格收购了总计455000股票。这位内部人士花了452,767.93美元购买了这些股票。
  • 发生了什么事?:Avalo Treateutics最近报告了AVTX-002在中到重度克罗恩病患者中的1b阶段结果,并在2022年投资者活动上公布了额外的计划更新。
  • Avalo治疗公司是做什么的:Avalo治疗公司是一家临床阶段的精密药物公司,为在免疫学、免疫肿瘤学和罕见遗传病方面有重大未满足临床需求的患者发现、开发和商业化靶向治疗。

IronNet

铁网

  • The Trade: IronNet, Inc. (NYSE:IRNT) Director Michael Rogers acquired a total of 13297 shares at an average price of $3.50. The insider spent $ $46,539.50 to buy those shares.
  • What's Happening: IronNet reported expansion of partnership with New York Power Authority to defend key supply chain partners with collective defense.
  • What IronNet Does: IronNet Inc is a global cybersecurity leader that is transforming how organizations secure their networks by delivering the first-ever Collective Defense platform operating at scale.
  • 《贸易》铁网,Inc.(纽约证券交易所代码:IRNT)董事迈克尔·罗杰斯以3.5美元的平均价格收购了总计13297股。这位内部人士花了46,539.50美元购买了这些股票。
  • 发生了什么事?:IronNet报告扩大了与纽约电力局的合作伙伴关系,以集体防御保护关键供应链合作伙伴。
  • IronNet做了什么:IronNet Inc.是一家全球网络安全领导者,通过提供有史以来第一个大规模运营的集体防御平台,该公司正在改变组织保护其网络的方式。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发